Logo image of SBRA

SABRA HEALTH CARE REIT INC (SBRA) Stock Fundamental Analysis

USA - NASDAQ:SBRA - US78573L1061 - REIT

19.08 USD
+0.2 (+1.06%)
Last: 11/10/2025, 8:00:02 PM
19.08 USD
0 (0%)
After Hours: 11/10/2025, 8:00:02 PM
Fundamental Rating

6

Taking everything into account, SBRA scores 6 out of 10 in our fundamental rating. SBRA was compared to 128 industry peers in the Diversified REITs industry. SBRA has an average financial health and profitability rating. SBRA is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make SBRA suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SBRA was profitable.
In the past year SBRA had a positive cash flow from operations.
In multiple years SBRA reported negative net income over the last 5 years.
In the past 5 years SBRA always reported a positive cash flow from operatings.
SBRA Yearly Net Income VS EBIT VS OCF VS FCFSBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

With a decent Return On Assets value of 3.42%, SBRA is doing good in the industry, outperforming 79.69% of the companies in the same industry.
SBRA has a Return On Equity of 6.72%. This is in the better half of the industry: SBRA outperforms 78.13% of its industry peers.
SBRA has a better Return On Invested Capital (4.11%) than 75.78% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SBRA is in line with the industry average of 3.08%.
The 3 year average ROIC (3.52%) for SBRA is below the current ROIC(4.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.42%
ROE 6.72%
ROIC 4.11%
ROA(3y)0.43%
ROA(5y)0.34%
ROE(3y)0.86%
ROE(5y)0.66%
ROIC(3y)3.52%
ROIC(5y)3.4%
SBRA Yearly ROA, ROE, ROICSBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

SBRA has a Profit Margin of 24.87%. This is in the better half of the industry: SBRA outperforms 76.56% of its industry peers.
In the last couple of years the Profit Margin of SBRA has grown nicely.
Looking at the Operating Margin, with a value of 37.04%, SBRA is in the better half of the industry, outperforming 78.13% of the companies in the same industry.
In the last couple of years the Operating Margin of SBRA has declined.
The Gross Margin of SBRA (69.46%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SBRA has declined.
Industry RankSector Rank
OM 37.04%
PM (TTM) 24.87%
GM 69.46%
OM growth 3Y-0.95%
OM growth 5Y-4.46%
PM growth 3YN/A
PM growth 5Y9.21%
GM growth 3Y-4.03%
GM growth 5Y-3.89%
SBRA Yearly Profit, Operating, Gross MarginsSBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

SBRA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SBRA has more shares outstanding than it did 1 year ago.
SBRA has more shares outstanding than it did 5 years ago.
SBRA has a worse debt/assets ratio than last year.
SBRA Yearly Shares OutstandingSBRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
SBRA Yearly Total Debt VS Total AssetsSBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that SBRA is in the distress zone and has some risk of bankruptcy.
SBRA has a better Altman-Z score (0.87) than 70.31% of its industry peers.
SBRA has a debt to FCF ratio of 13.98. This is a negative value and a sign of low solvency as SBRA would need 13.98 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.98, SBRA belongs to the top of the industry, outperforming 85.16% of the companies in the same industry.
SBRA has a Debt/Equity ratio of 0.91. This is a neutral value indicating SBRA is somewhat dependend on debt financing.
SBRA has a better Debt to Equity ratio (0.91) than 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 13.98
Altman-Z 0.87
ROIC/WACC0.6
WACC6.91%
SBRA Yearly LT Debt VS Equity VS FCFSBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

SBRA has a Current Ratio of 2.15. This indicates that SBRA is financially healthy and has no problem in meeting its short term obligations.
SBRA has a better Current ratio (2.15) than 83.59% of its industry peers.
SBRA has a Quick Ratio of 2.15. This indicates that SBRA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SBRA (2.15) is better than 83.59% of its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 2.15
SBRA Yearly Current Assets VS Current LiabilitesSBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

SBRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.61%, which is quite impressive.
The Earnings Per Share has been growing by 9.28% on average over the past years. This is quite good.
SBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.61%.
The Revenue has been growing slightly by 3.41% on average over the past years.
EPS 1Y (TTM)75.61%
EPS 3YN/A
EPS 5Y9.28%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)8.61%
Revenue growth 3Y7.31%
Revenue growth 5Y3.41%
Sales Q2Q%6.76%

3.2 Future

Based on estimates for the next years, SBRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.42% on average per year.
Based on estimates for the next years, SBRA will show a quite strong growth in Revenue. The Revenue will grow by 9.62% on average per year.
EPS Next Y47.55%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue Next Year7.85%
Revenue Next 2Y8.44%
Revenue Next 3Y9.83%
Revenue Next 5Y9.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBRA Yearly Revenue VS EstimatesSBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SBRA Yearly EPS VS EstimatesSBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

SBRA is valuated quite expensively with a Price/Earnings ratio of 26.50.
71.88% of the companies in the same industry are more expensive than SBRA, based on the Price/Earnings ratio.
SBRA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.28.
The Price/Forward Earnings ratio is 23.78, which indicates a rather expensive current valuation of SBRA.
Based on the Price/Forward Earnings ratio, SBRA is valued cheaper than 86.72% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SBRA to the average of the S&P500 Index (33.61), we can say SBRA is valued slightly cheaper.
Industry RankSector Rank
PE 26.5
Fwd PE 23.78
SBRA Price Earnings VS Forward Price EarningsSBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

SBRA's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, SBRA is valued a bit cheaper than the industry average as 72.66% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.79
EV/EBITDA 15.58
SBRA Per share dataSBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SBRA has a very decent profitability rating, which may justify a higher PE ratio.
SBRA's earnings are expected to grow with 16.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)2.85
EPS Next 2Y23.04%
EPS Next 3Y16.42%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.36%, SBRA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.28, SBRA pays a bit more dividend than its industry peers.
SBRA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.36%

5.2 History

The dividend of SBRA decreases each year by -7.34%.
SBRA has paid a dividend for at least 10 years, which is a reliable track record.
SBRA has decreased its dividend recently.
Dividend Growth(5Y)-7.34%
Div Incr Years0
Div Non Decr Years1
SBRA Yearly Dividends per shareSBRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

SBRA pays out 155.77% of its income as dividend. This is not a sustainable payout ratio.
DP155.77%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
SBRA Yearly Income VS Free CF VS DividendSBRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
SBRA Dividend Payout.SBRA Dividend Payout, showing the Payout Ratio.SBRA Dividend Payout.PayoutRetained Earnings

SABRA HEALTH CARE REIT INC

NASDAQ:SBRA (11/10/2025, 8:00:02 PM)

After market: 19.08 0 (0%)

19.08

+0.2 (+1.06%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners100.95%
Inst Owner Change0.81%
Ins Owners1.03%
Ins Owner Change3.51%
Market Cap4.58B
Revenue(TTM)703.24M
Net Income(TTM)182.33M
Analysts76
Price Target20.91 (9.59%)
Short Float %8.01%
Short Ratio7.42
Dividend
Industry RankSector Rank
Dividend Yield 6.36%
Yearly Dividend1.2
Dividend Growth(5Y)-7.34%
DP155.77%
Div Incr Years0
Div Non Decr Years1
Ex-Date11-17 2025-11-17 (0.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.71%
Min EPS beat(2)-3.84%
Max EPS beat(2)51.26%
EPS beat(4)2
Avg EPS beat(4)10.7%
Min EPS beat(4)-18.65%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-26.88%
EPS beat(12)2
Avg EPS beat(12)-82.02%
EPS beat(16)3
Avg EPS beat(16)-80.22%
Revenue beat(2)2
Avg Revenue beat(2)1.82%
Min Revenue beat(2)0.88%
Max Revenue beat(2)2.77%
Revenue beat(4)4
Avg Revenue beat(4)1.34%
Min Revenue beat(4)0.46%
Max Revenue beat(4)2.77%
Revenue beat(8)7
Avg Revenue beat(8)1.58%
Revenue beat(12)8
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-1.26%
PT rev (1m)-0.22%
PT rev (3m)3.44%
EPS NQ rev (1m)1.59%
EPS NQ rev (3m)2.54%
EPS NY rev (1m)3.14%
EPS NY rev (3m)8.75%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)1.02%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 26.5
Fwd PE 23.78
P/S 6.24
P/FCF 25.79
P/OCF 13.5
P/B 1.69
P/tB 1.7
EV/EBITDA 15.58
EPS(TTM)0.72
EY3.77%
EPS(NY)0.8
Fwd EY4.21%
FCF(TTM)0.74
FCFY3.88%
OCF(TTM)1.41
OCFY7.41%
SpS3.06
BVpS11.31
TBVpS11.2
PEG (NY)0.56
PEG (5Y)2.85
Graham Number13.53
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 6.72%
ROCE 5.21%
ROIC 4.11%
ROICexc 4.19%
ROICexgc 4.21%
OM 37.04%
PM (TTM) 24.87%
GM 69.46%
FCFM 24.2%
ROA(3y)0.43%
ROA(5y)0.34%
ROE(3y)0.86%
ROE(5y)0.66%
ROIC(3y)3.52%
ROIC(5y)3.4%
ROICexc(3y)3.55%
ROICexc(5y)3.44%
ROICexgc(3y)3.57%
ROICexgc(5y)3.46%
ROCE(3y)4.45%
ROCE(5y)4.3%
ROICexgc growth 3Y10.05%
ROICexgc growth 5Y1.42%
ROICexc growth 3Y10.2%
ROICexc growth 5Y1.69%
OM growth 3Y-0.95%
OM growth 5Y-4.46%
PM growth 3YN/A
PM growth 5Y9.21%
GM growth 3Y-4.03%
GM growth 5Y-3.89%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 13.98
Debt/EBITDA 5.59
Cap/Depr 93.8%
Cap/Sales 22.02%
Interest Coverage 2.61
Cash Conversion 76.37%
Profit Quality 97.3%
Current Ratio 2.15
Quick Ratio 2.15
Altman-Z 0.87
F-Score6
WACC6.91%
ROIC/WACC0.6
Cap/Depr(3y)57.48%
Cap/Depr(5y)56.11%
Cap/Sales(3y)15.43%
Cap/Sales(5y)15.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.61%
EPS 3YN/A
EPS 5Y9.28%
EPS Q2Q%-30.77%
EPS Next Y47.55%
EPS Next 2Y23.04%
EPS Next 3Y16.42%
EPS Next 5YN/A
Revenue 1Y (TTM)8.61%
Revenue growth 3Y7.31%
Revenue growth 5Y3.41%
Sales Q2Q%6.76%
Revenue Next Year7.85%
Revenue Next 2Y8.44%
Revenue Next 3Y9.83%
Revenue Next 5Y9.62%
EBIT growth 1Y14.09%
EBIT growth 3Y6.29%
EBIT growth 5Y-1.21%
EBIT Next Year83.79%
EBIT Next 3Y27.39%
EBIT Next 5Y19.52%
FCF growth 1Y-12.79%
FCF growth 3Y-12.17%
FCF growth 5Y-11.54%
OCF growth 1Y7.68%
OCF growth 3Y-4.49%
OCF growth 5Y-3.57%

SABRA HEALTH CARE REIT INC / SBRA FAQ

What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SBRA.


What is the valuation status for SBRA stock?

ChartMill assigns a valuation rating of 5 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Fairly Valued.


How profitable is SABRA HEALTH CARE REIT INC (SBRA) stock?

SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SBRA stock?

The Price/Earnings (PE) ratio for SABRA HEALTH CARE REIT INC (SBRA) is 26.5 and the Price/Book (PB) ratio is 1.69.


Can you provide the financial health for SBRA stock?

The financial health rating of SABRA HEALTH CARE REIT INC (SBRA) is 6 / 10.